Nippon India Pharma Fund Growth

Fund Name : Nippon India Mutual Fund
Scheme Name : Nippon India Pharma Fund Growth
AMC : Nippon India Mutual Fund
Type : Open
Category : Equity - Pharma
Launch Date : 10-May-04
Fund Manager : Sailesh Raj Bhan
Net Assets (Rs. cr) : 2850.69

Nippon India Pharma Fund Growth - NAV Details

NAV Date : 28-May-20
NAV [Rs.] : 181.6
Buy/Resale Price [Rs.] : 0
Sell/Repurchase Price [Rs.] : 0
Entry Load % : Nil
Exit Load % : Nil

Nippon India Pharma Fund Growth - NAV Chart

Nippon India Pharma Fund Growth - Performance(%)

* returns above 1 yr. are annualized
  1w 1m 3m 6m 1y 3y 5y Since INC
Scheme Returns [1.08] 1.10 16.59 18.84 25.35 15.11 6.20 19.88
Category Avg [0.49] [1.85] 10.96 17.81 26.78 10.46 3.30 14.73
Category Best [0.16] [0.72] 14.50 23.41 34.30 16.05 7.01 23.80
Category Worst [1.02] [2.72] 4.06 13.84 22.87 5.42 [0.13] 1.86

Nippon India Pharma Fund Growth - Latest Dividends

  Dividends Bonus
Ratio NA NA
Date NA NA

Nippon India Pharma Fund Growth - Investment Details

Min. Investment(Rs.) : 5000
Increm.Investment(Rs.) : 1

In & Out

In
Name of the Company No of shares
No Data Found
Out
Name of the Company No of shares
Apollo Hospitals 100000
Astrazeneca Phar 8591

Fund Holdings

Asset Type Instrument Name Industry Net Assets(%) No of Shares Mkt Value(Cr.)
Equity & Equity related Investments
Equity Aurobindo Pharma Pharmaceuticals 10.98 5,000,000.00 312.93
Equity Dr Reddy's Labs Pharmaceuticals 10.36 750,000.00 295.22
Equity Sun Pharma.Inds. Pharmaceuticals 10.27 6,300,976.00 292.65
Equity Divi's Lab. Pharmaceuticals 9 1,100,075.00 256.64
Equity Cipla Pharmaceuticals 7.86 3,800,000.00 224.05
Equity Lupin Pharmaceuticals 7.33 2,500,025.00 208.83
Equity Syngene Intl. Pharmaceuticals 4.86 4,300,000.00 138.50
Equity Sanofi India Pharmaceuticals 4.77 175,000.00 136.12
Equity Fortis Health. Healthcare Services 4.72 10,603,541.00 134.67
Equity Thyrocare Tech. Healthcare Services 4.53 2,539,512.00 129.19
Equity Abbott India Pharmaceuticals 4.36 70,147.00 124.38
Equity Biocon Pharmaceuticals 4.36 3,507,778.00 124.16
Equity Cadila Health. Pharmaceuticals 3.97 3,491,846.00 113.12
Equity Alkem Lab Pharmaceuticals 3.57 391,094.00 101.66
Equity Narayana Hrudaya Healthcare Services 2.78 2,837,502.00 79.34
Equity Indoco Remedies Pharmaceuticals 2.50 3,045,783.00 71.18
Equity Health.Global Healthcare Services 0.26 1,047,962.00 7.34
 
Derivative Investments
Derivatives Derivatives -/- 0.05 0.00 1.35
 
Cash & Cash Equivalent
Reverse Repo TREPS -/- 3.89 0.00 110.98
Cash & Cash Equivalent Cash & Cash Equivalent -/- 0 0.00 0
Net CA & Others Net CA & Others -/- [0.42] 0.00 [11.59]
 
 
Fund Manager Speak
My wealth at retirement

Calculate the worth of your wealth at retirement

My age (years)
Age I plan to retire (years)
Current savings (Rs.)
Monthly savings (Rs.)
ROI(% p.a.)
Key Information
Fund House : Nippon India Mutual Fund
Incorporation Date : 24-Feb-1995
Total Assets Managed (Cr.) : 205,720.09
Trustee/s : Nippon Life India Trustee
Chairman : N/A
CEO / MD : Mr. Sundeep Sikka
CIO : N/A
President : N/A
Director/s : Mr. Takayuki Murai
Compliance Officer/s : Mr. Muneesh Sud
Investor Service Officer/s : Mr. Bhalchandra Joshi
Fund Manager/s : Sailesh Raj Bhan
Other Information
Auditors : N/A
Registered Office : Reliance Center, 7th Floor South Wing, Off Western Express Highway, Santacruz(E) Mumbai-400055
Contact Nos : 022-43031000/1860 266 0111
Fax : 022-43037662
Email : customercare@nipponindiamf.com
Website : www.nipponindiamf.com